WATERS CORP /DE/·4

Feb 27, 7:18 PM ET

Fraser Claire 4

4 · WATERS CORP /DE/ · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Waters (WAT) Director Claire Fraser Receives Stock Award

What Happened Claire Fraser, a director of Waters Corp. (WAT), was granted equity awards on Feb 25, 2026: 358 restricted shares of common stock (acquired at $0.00) and an award covering 877 option shares (derivative award, $0.00). The reported grants have no purchase price ($0) and together represent 1,235 shares of economic exposure via restricted stock and an option award.

Key Details

  • Transaction date: 2026-02-25; Filing date: 2026-02-27 (filed within the normal two-business-day Form 4 window).
  • Grants: 358 restricted shares @ $0.00; 877 shares as a derivative award @ $0.00.
  • Total immediate cash paid: $0.00 (award/grant).
  • Shares owned after transaction: Not disclosed in this filing.
  • Footnotes:
    • F1: The 358 restricted shares are subject to restrictions that lapse 100% on Feb 9, 2027.
    • F2: The 877 option shares will vest and become exercisable on Feb 9, 2027.
  • Transaction code: A = Award/Grant.

Context These awards are standard director equity compensation (not a sale or open-market purchase). The derivative award indicates stock options or similar rights that do not become exercisable until the stated vesting date; there is no indication the options were exercised or shares sold. Such awards are common for board members and do not by themselves indicate buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-25+358489 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-02-25+877877 total
    Exercise: $319.44From: 2027-02-09Exp: 2036-02-25Common Stock (877 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.
  • [F2]All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.
Signature
/s/ Michael Lynn, attorney-in-fact for Claire Fraser|2026-02-27

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT